Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06597175

Completed

Evaluating Investigational Medical Device for Breast Tumor Diagnosis Using Diffusion Optical Spectroscopy (ORIGO)

Breast Cancer | Breast Tumor | Mammary Carcinoma, Human
NCT07086196

Completed

A Study of Real-World Outcomes of Ribociclib in First-Line Treatment for Metastatic HR+/HER2- Breast Cancer

Metastatic HR+/HER2- Breast Cancer
NCT02238808

Active, not recruiting

A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers (PRESTO)

Estrogen Receptor Positive Breast Cancer
NCT06945224

Active, not recruiting

A ReaL World Study of DS-8201 (EXPLORE)

Breast Cancer Metastatic | Treatment Efficacy
NCT02216786

Completed

A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer (MANTA)

Estrogen Receptor Positive Breast Cancer
NCT03395899

Completed

Pre-operative Immunotherapy Combination Strategies in Breast Cancer (ECLIPSE)

Breast Cancer | Estrogen Receptor-positive Breast Cancer
NCT02599714

Completed

Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer (PASTOR)

Advanced and Metastatic Breast Cancer
NCT01988324

Completed

AR and ER Imaging in Metastatic Breast Cancer

Metastatic Breast Cancer
NCT06006910

Completed

Electronic Medical Record-Based Nudge to Reduce SLNB

Breast Cancer | Estrogen-receptor-positive Breast Cancer
NCT04869943

Terminated

Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer (ARTEST)

Metastatic Breast Cancer
NCT05261269

Completed

A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer

HER2-negative Metastatic Breast Cancer
NCT06098599

Completed

Comparing the Pharmacokinetic Profile of LY01612 and CAELYX® in Chinese Subjects With Advanced Breast Cancer

Advanced Breast Cancer
NCT04681287

Active, not recruiting

Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.

HER2 Positive Metastatic Breast Cancer
NCT01303679

Terminated

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

First Line Metastatic Breast Cancer
NCT04778982

Terminated

Study of KN026 in Combination With Palbociclib and Fulvestrant in Patients With Advanced Breast Cancer

HER2-positive Metastatic Breast Cancer
NCT02067741

Terminated

CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer

Breast Cancer | Metastatic Breast Adenocarcinoma
NCT03829306

Completed

Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA) (KATIA)

Advanced Breast Cancer
NCT04586517

Active, not recruiting

Effect of Heavy-load Resistance Training During Chemotherapy on Muscle Cellular Outcomes

Breast Cancer Female
NCT02973737

Active, not recruiting

A Study of Pyrotinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer

HER2 Positive Metastatic Breast Cancer
NCT03596658

Terminated

SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer

ER+ HER2- Advanced Breast Cancer
NCT04903652

Completed

Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer

HER2-positive Advanced Breast Cancer
NCT01976169

Completed

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)

Advanced Breast Cancer
NCT04038489

Withdrawn

COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer (Breast 51)

Breast Cancer | Estrogen Receptor-positive Breast Cancer
NCT02988986

Completed

TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer (ANETT)

Estrogen Receptor Positive Breast Cancer
NCT01808573

Completed

A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting (NALA)

HER2+ Metastatic Breast Cancer (MBC)
NCT04744766

Completed

Central Mammary Duct Excision; How to Improve the Outcome? (MDE)

Benign Breast Disease | Duct Ectasia Breast
NCT03176238

Completed

Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer (EVEREXES)

Post Menopausal Breast Cancer
NCT02073916

Completed

T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer (STELA)

Metastatic Breast Cancer
NCT02676336

Completed

A Randomized Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Safety, Tolerability and Potential Effects of the Dietary Supplement Violet™ Molecular Iodine (I2) on Breast Health in Women With Cyclic Breast Discomfort and Tenderness

Fibrocystic Breast Condition (FBC)
NCT02414776

Terminated

Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy (ABC01)

Estrogen Receptor Positive Breast Cancer
NCT00679211

Completed

A Study of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer

Metastatic Breast Cancer
NCT02008734

Completed

Randomized Phase II Study to Assess PD 0332991 in Breast Cancer (POP)

Untreated Operable Early Breast Cancer
NCT06297265

Recruiting

Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery

Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Localized Breast Carcinoma
NCT01149083

Completed

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Unresectable Breast Carcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma
NCT00684983

Completed

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

Recurrent Breast Carcinoma | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7
NCT07317778

Not yet recruiting

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

Breast Cancer Early Stage Breast Cancer (Stage 1-3) | HR Positive/HER2 Low Breast Cancer
NCT02129686

Completed

A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients

Stage I Breast Cancer | Stage II Breast Cancer | Early-Stage Breast Carcinoma | Stage III Breast Cancer | Chemotherapy-induced Peripheral Neuropathy (CIPN) | Taxane-induced Peripheral Neuropathy
NCT03505671

Completed

Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8
NCT07542496

Recruiting

Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease (PERTUREAL)

Breast Cancer | Her 2 Positive Breast Cancer
NCT07503717

Recruiting

SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveillance (SURVEY-CNS)

Breast Cancer | HER2-Positive Metastatic Breast Cancer
NCT07411651

Not yet recruiting

Confirmation of the Link Between Endocrine Disruptors Exposure and Breast Cancer and Identification of Biological Response Biomarkers (EXPOSAL)

Breast Cancer | Breast Lesions | Metabolomics | Endocrine Disruptors
NCT07125950

Not yet recruiting

SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer

Advanced Breast Cancer
NCT07067788

Recruiting

B.Brilliant Revelation Comparision Study

Breast Cancer Screening
NCT07066917

Recruiting

Mechanisms of Response and Resistance to Innovative Treatments in Patients With Locally Advanced or Metastatic Breast Cancer (PANDORA)

Metastatic Breast Cancer
NCT07041762

Recruiting

Rhomboid Intercostal Block With Sub-Serratus Plane Block Versus Erector Spinae Block (RISS-ESPB)

Breast Cancer Patients
NCT07008976

Recruiting

Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer

Metastatic Breast Cancer
NCT06991946

Recruiting

Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain (HOPE-Focus)

Metastatic Breast Cancer
NCT06977698

Recruiting

Intra-operative Detection of Positive Margins in Breast Surgery

Breast Cancer Invasive
NCT06941142

Not yet recruiting

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

Advanced Breast Cancer
NCT06876610

Recruiting

Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer

Breast Cancer Screening

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations